Antimetabolites as an adjunct to dacryocystorhinostomy for nasolacrimal duct obstruction
- 9 August 2016
- journal article
- research article
- Published by Wiley in Cochrane Database of Systematic Reviews
- No. 8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Evidence-based review of surgical practices in endoscopic endonasal dacryocystorhinostomy for primary acquired nasolacrimal duct obstruction and other new indicationsCurrent Opinion in Ophthalmology, 2014
- Systematic Review and Meta-Analysis on Outcomes for Endoscopic Versus External DacryocystorhinostomyOrbit, 2013
- Ostium Shrinkage after Endoscopic DacryocystorhinostomyOphthalmology, 2013
- Success Rates in Powered Endonasal Revision Surgery for Failed Dacryocystorhinostomy in a Tertiary Referral CenterOphthalmic Plastic & Reconstructive Surgery, 2013
- Diode laser-assisted endoscopic dacryocystorhinostomy: a comparison of three different combinations of adjunctive proceduresEuropean Archives of Oto-Rhino-Laryngology, 2013
- Prospective Randomized Comparison of Mitomycin C Application in Endoscopic and External DacryocystorhinostomyIndian Journal of Otolaryngology and Head & Neck Surgery, 2011
- The Efficacy of 5-Fluorouracil Bleb Needling Performed 1 Year or More PosttrabeculectomyJournal of Glaucoma, 2009
- Stepwise Treatment Paradigm for Congenital Nasolacrimal Duct ObstructionOphthalmic Plastic & Reconstructive Surgery, 2006
- Efficacy and safety of mitomycin-C in primary trabeculectomyOphthalmology, 2002
- A Randomized Trial Comparing Mitomycin C and Conjunctival Autograft After Excision of Primary PterygiumAmerican Journal of Ophthalmology, 1995